Rocket Pharmaceuticals, Inc. raised approximately $178.1 million by selling 13.2 million shares at $12.50 each, with an additional option for 1.98 million shares, and also secured $4.7 million from a private placement of pre-funded warrants for 400,000 shares at $12.49 each, both aimed at funding pipeline development and general corporate purposes.